{"nctId":"NCT00490555","briefTitle":"PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue","startDateStruct":{"date":"2009-01"},"conditions":["Healthy"],"count":32,"armGroups":[{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo Testosterone gel","Other: Placebo dutasteride","Other: Placebo DMPA"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Testosterone gel"]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Testosterone gel","Drug: Dutasteride"]},{"label":"4","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Testosterone gel","Drug: Depo-Medroxyprogesterone (DMPA)","Other: Placebo dutasteride"]}],"interventions":[{"name":"Testosterone gel","otherNames":["Testim"]},{"name":"Dutasteride","otherNames":["Avodart"]},{"name":"Depo-Medroxyprogesterone (DMPA)","otherNames":["Depo-Provera"]},{"name":"Placebo Testosterone gel","otherNames":[]},{"name":"Placebo dutasteride","otherNames":[]},{"name":"Placebo DMPA","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men in good health, and without a history of chronic androgen therapy or known history of gonadal or prostate abnormalities.\n\n  * PSA ≤ 2.\n  * Age 25-55 years\n  * Ability to understand the study,study procedures and provide consent\n  * Normal serum total T, LH, FSH, urine analyses, and sperm count \\> or equal to 15million/ml\n  * International Prostate Symptom Score (IPSS) \\< 10\n  * Normal seminal fluid analysis (\\>20 million sperm/ml)\n  * Agree not to donate blood during the treatment and recovery periods\n\nExclusion Criteria:\n\n* A history or evidence of prostate or breast cancer\n* History of invasive therapy for BPH\n* History of acute urinary retention\n* Current or past treatment with a 5α-reductase inhibitor\n* History of anti/androgenic drugs or drugs that interfere with steroid metabolism within past 3 months\n* Severe systemic illness (renal, liver, cardiac, lung disease, cancer, poorly controlled diabetes)\n* Known untreated obstructive sleep apnea\n* Hematocrit \\> 52%\n* Skin disease that might interfere with T gel absorption\n* Hypersensitivity to any of the drugs used in the study\n* History of a bleeding disorder or anticoagulation\n* History of drug or alcohol abuse within 12 months\n* History of infertility or desire for fertility within 12 months, or current pregnant partner\n* A first-degree relative (i.e. father, brother) with a history of prostate cancer\n* Abnormal digital rectal examination or prostate ultrasound","healthyVolunteers":true,"sex":"MALE","minimumAge":"25 Years","maximumAge":"55 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Prostate-specific Antigen (PSA)","description":"PSA level week 10 end of treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":null},{"groupId":"OG001","value":"0.9","spread":null},{"groupId":"OG002","value":"0.7","spread":null},{"groupId":"OG003","value":"0.4","spread":null}]}]}]},{"type":"PRIMARY","title":"Testosterone Concentration","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":null},{"groupId":"OG001","value":"4.4","spread":null},{"groupId":"OG002","value":"7.0","spread":null},{"groupId":"OG003","value":"1.8","spread":null}]}]}]},{"type":"PRIMARY","title":"Dihydrotestosterone (DHT) Concentration","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":null},{"groupId":"OG001","value":"1.8","spread":null},{"groupId":"OG002","value":"0.5","spread":null},{"groupId":"OG003","value":"0.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Androstenedione (AED)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null},{"groupId":"OG001","value":"0.9","spread":null},{"groupId":"OG002","value":"1.8","spread":null},{"groupId":"OG003","value":"0.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Dehydroepiandrosterone (DHEA)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":null},{"groupId":"OG001","value":"3.5","spread":null},{"groupId":"OG002","value":"3.8","spread":null},{"groupId":"OG003","value":"3.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":8},"commonTop":["headache","Fatigue","rash","abscess"]}}}